Ophthalmology
The Association of Retinal Disease with Vision Impairment and Functional Status in Medicare Patients
This study examined patient-reported survey data linked with Medicare claims to describe the burden of these vision-threatening retinal diseases among Medicare beneficiaries.
To evaluate whether infliximab, a modern off-label biologic, is cost-effective for treating posterior uveitis and panuveitis compared to current standards of care, methotrexate and prednisone.